ArticleFrontiers in immunology2022

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.

Amir Ghaemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.